Guggenheim Capital LLC Buys 670 Shares of Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE)
Guggenheim Capital LLC lifted its stake in shares of Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE – Free Report) by 1.5% in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 45,222 shares of the biopharmaceutical company’s stock after acquiring an additional 670 shares during the quarter. […]
Guggenheim Capital LLC lifted its stake in shares of Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE – Free Report) by 1.5% in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 45,222 shares of the biopharmaceutical company’s stock after acquiring an additional 670 shares during the quarter. […]